global conformational change associated with the two-step ... · b1 a1 b2 b3 a2 a3 b4 b5 b6 a4 b7...
TRANSCRIPT
Supplemental Data
Global Conformational Change Associated with the Two-step Reaction Catalyzed by Escherichia coli Lipoate-protein Ligase A
Kazuko Fujiwara, Nobuo Maita, Harumi Hosaka, Kazuko Okamura-Ikeda, Atsushi Nakagawa, and
Hisaaki Taniguchi
Supplemental TABLE S1 Primers used for mutagenesis. Mutant Sequence
LplA-K133A sensea 5’-GGCGACCGCGCAGTCTCAGGCTC-3’ LplA-N121A sensea 5’-GTCCGGACGTGCCGATCTGGTGG-3’ LplA-N122A sensea 5’-CGGACGTAACGCTCTGGTGGTGA-3’ H-protein-K64A sensea 5’-CGAATCGGTAGCAGCGGCGTC-3’
LplA-H149A sense 5’-GCTTCCACGCCGGCACCTTGCTACTC-3’ anti-sense 5’-TGCCGGCGTGGAAGCCGCGATCTTTG-3’ aA sense and complementary anti-sense primer set was used. Modified bases are shown in bold.
1
Supplemental TABLE S2 Potential hydrogen bond and electrostatic interactions between LplA and octyl-AMP or apoH-protein in the LplA·octyl-AMP·apoH-protein ternary complex LplA (molA) OAMa (molA) distance (Å) LplA (molC) OAMa (molC) distance (Å) F78/O — AMP/N6 2.9 F78/O — AMP/N6 2.9 N83/Oδ1 — AMP/N6 2.9 N83/Oδ1 — AMP/N6 3.1 T151/Oγ1 — AMP/ N1 2.7 T151/Oγ1 — AMP/N1 2.9 S182/N — AMP/O2* 3.3 S182/N — AMP/O2* 3.3 V180/N — AMP/O2P 2.8 G75/N — AMP/O2P 2.9 K133/Nζ — AMP/O4* 3.0 K133/Nζ — AMP/O5* 3.1 G75/N — AMP/O3P 2.9 LplA (molA) apoHb (molB) distance (Å) LplA (molC) apoHb (molD) distance (Å) R47/NH1 — D43/Oδ2 2.6 R47/NH1 — D43/Oδ2 3.6 R47/NH2 — D43/Oδ2 3.0 G74/N — E61/Oε2 3.6 G74/N — E61/Oε2 2.9 Y139/O — A66/N 3.0 Y139/O — A66/N 2.9 R140/Nε — A66/O 3.0 R140/NH1 — D68/Oδ1 3.4 R140/Nε — D68/Oδ2 3.0 R140/NH1 — D68/Oδ2 3.6 R140/NH2 — D68/Oδ2 3.3 E141/N — A66/O 2.9 E141/N — A66/O 3.1 E141/O — D68/N 2.9 E141/O — D68/N 3.3 K143/N — Y70/Oη 2.9 K143/Nε — D68/O 3.1 K175/Nζ — D86/Oδ1 2.6 K143/N — Y70/Oη 3.5 K175/Nζ — D86/Oδ2 3.5 K175/Nζ — S85/O 3.2 K272/Nζ — E46/Oε1 3.1 K175/Nζ — D86/Oδ1 2.2 K272/Nζ — E46/Oε2 3.1 aOAM: octyl-AMP bapoH: apoH-protein
2
Ec LplA-lip-AMP S T L R L L I S D S Y D PWF N L A V E E C I F R QM P A T Q R - V L F LWR N S P T V V I G R A Q N PWK E C N T 57Ec LplA S T L R L L I S D S Y D PWF N L A V E E C I F R QM P A T Q R - V L F LWR N S P T V V I G R A Q N PWK E C N T 57Sp LplA MK Y I I N H S N D T A F N I A L E E Y A F K H L L D E D Q - I F L LW I N K P S I I V G R H Q N T I E E I N R 55Ta LplA ME G R L L L L E T P G N T RM S L A Y D E A I Y R S F Q Y G D K P I L R F Y R H D R S V I I G Y F Q V A E E E V D L 59bLT T V K S G L I L Q S I S N D V Y H N L A V E DW I H D HMN L E G K P V L F LWR N S P T V V I G R H Q N PWQ E C N L 60
Ec LplA-lip-AMP R RME E D N V R L A R R S S G G G A V F H D L G N T C F T FMA G K P E - - - - Y D K T I S T S I V L N A L N A L G - 112Ec LplA R RME E D N V R L A R R S S G G G A V F H D L G N T C F T FMA G K P E - - - - Y D K T I S T S I V L N A L N A L G - 112Sp LplA D Y V R E N G I E V V R R I S G G G A V Y H D L N N L N Y T I I S K E D E N K A - F D F K S F S T P V I N T L A Q L G - 113Ta LplA D YMK K N G I ML A R R Y T G G G A V Y H D L G D L N F S V V R S S D DMD I T S M F R TMN E A V V N S L R I L G - 118bLT N LMR E E G V K L A R R R S G G G T V Y H DMG N I N L T F F T T K K K - - - - Y D RME N L K L V V R A L K A V H P 116
Ec LplA-lip-AMP - V S A E A S G R N D L V V K T - - - - - - V E G D R K V S G S A Y R E T K D R G F H H G T L L L N A - D L S R L A N Y 164Ec LplA - V S A E A S G R N D L V V K T - - - - - - V E G D R K V S G S A Y R E T K D R G F H H G T L L L N A - D L S R L A N Y 164Sp LplA - V K A E F T G R N D L E I D - - - - - - - - - - G K K F C G N A Q A Y I N G R I MH H G C L L F D V - D L S V L A N A 161Ta LplA - L D A R P G E L N D V S I P V N K K T D I MA G E K K I MG A A G AMR K G A K LWH A AML V H T - D L DML S A V 176bLT H L D V Q A T K R F D L L L D - - - - - - - - - G Q F K I S G T A S K I G R N A A Y H H C T L L C G T - D G T F L S S L 166
Ec LplA-lip-AMP L N P D K K K L A A K G I T S V R S R V T N L T E L L P G I T H E Q V C E A I T E A F F A H Y G E R V E A E I I S P N K 224Ec LplA L N P D K K K L A A K G I T S V R S R V T N L T E L L P G I T H E Q V C E A I T E A F F A H Y G E R V E A E I I S P N K 224Sp LplA L K V S K D K F E S K G V K S V R A R V T N I I N E L P K K I T V E K F R D L L L E YMK K E Y P EMT E Y V F S E E E 221Ta LplA L K V P D E K F R D K I A K S T R E R V A N V T D - F V D V S I D E V R N A L I R G F S E T L H I D F R E D T I T E K E 235bLT L K S P Y Q G I R S N A T A S T P A L V K N LME K D P T L T C E V V I N A V A T E Y A T S H Q I D N H I H L I N P T D 226
Ec LplA-lip-AMP T P D L P N F A E T F A R Q S S WEWN F G Q A P A F S H L L D E R F TWG G - - - - V E L H F D V E K G - - H I T R A 278Ec LplA T P D L P N F A E T F A R Q S S WEWN F G Q A P A F S H L L D E R F TWG G - - - - V E L H F D V E K G - - H I T R A 278Sp LplA L A E I N R I K D T K F G - - TWDWN Y G K S P E F N V R R G I K F T S G K - - - - V E V F A N V T E S - - K I Q D I 273Ta LplA E S L A R E L F D K K Y S T E EWNMG L L R K E V V 262bLT E T V F P G I N S K A I E L Q TWEW I Y G K T P K F S V D T S F T V L H E Q S H V E I K V F I D V K N G R I E V C N I 286
Ec LplA-lip-AMP Q V F T D S L N P A P L E A L A G R L Q G C L Y R A DML Q Q E C E A L L V D F P E Q E K E L R E L S AWMA G A V R 337Ec LplA Q V F T D S L N P A P L E A L A G R L Q G C L Y R A DML Q Q E C E A L L V D F P E Q E K E L R E L S AWMA G A V R 337Sp LplA K I Y G D F F G I E D V A A V E D V L R G V K Y E R E D V L K A L K T I D I T R Y F A G I S R E E I A E A V V G 329bLT E A P D HWL P L E I C D Q L N S S L I G S K F S P I E T T V L T S I L H R T Y P G D D E L H S KWN I L C E K I K G I 346
bLT M 347
Supplemental Figure S1
α10α9 α11
α7 β13α8 β15β14
α1β1 α2β3β2
α3 β4 β5 β6 α4
α5β8β7 β9 β10
β12β11 α63101
3
FIGURE S1. Amino acid sequence alignment of E. coli LplA with secondary structural elements. Amino acid sequence of E. coli LplA is aligned with those from Streptococcus pneumoniae (Sp) (1VQZ), T. acidophilum (Ta) (2ART, 2C8M), and bovine lipoyltransferase (bLT) (2E5A). Sequence alignment was carried out using ClustalW (http://clustalw.genome.jp). Identical residues among four proteins are shown in red. The regions of α-helix, β-strand, and 310-helix are shown against yellow, blue, and orange backgrounds, respectively. Residues with red and green arrowheads interact with lipoyl-AMP with hydrophobic and hydrogen-bonding interactions, respectively. The lipoate-binding loop and adenylate-binding loop are shown by bars in magenta and yellow, respectively. The connecting loops between N- and C-terminal domains are shown by green bars. Ec LplA-lip-AMP and Ec LplA represent E. coli LplA in complex with lipoyl-AMP and in its unliganded form, respectively. The secondary structural elements were assigned by the program DSSP (1).
REFERENCE1. Kabsch, W., and Sander, C. (1983) Biopolymers 22, 2577-2637
Supplemental Figure S2
2.89
2.36
2.81
2.65
2.99
2.83
2.69
2.75
3.25
2.87
3.16
2.752.63
3.30
3.04
2.79
3.012.99
3.06
2.75
2.76
3.20
2.91
2.98
3.09
3.12
2.87
3.20
C16 C17
C15 S17
S15
C14
C13
C12
C11 C10
O10
O3P P
O2P
O1P
O5*
C5*
C4*
O4*
C3*
C1*
O3*
C2*
O2* N9
C8
C4
N7
C5 C6
N3 C2
N1
N6
N
CA CB
C CG CD
CE NZ
O
N
CA
CB
C
CG OD1
ND2
O
N
CA
CB
C
OG
O
N CA
CB
C
CG1
CG2
O
N
CA
C O
N
CA CB
C
CG
CD1 CD2
CE1
CZ
CE2
O
N
CA
CB
C
CG
CD
NE CZ
NH1
NH2
O
N
CA
CB
C
CG
OD1
ND2
O
N
CA
CB
C
OG1
CG2
O
N
CA CB
C OG1
CG2
O
N
CA
CB
C O
Val 77(A)
Trp 37(A)
Val 44(A)
His 149(A)
Arg 70(A)
His 79(A)
Gly 150(A)
Leu 153(A)
Ser 135(A)
Gly 136(A)
Ser 137(A)
Leu 161(A)
Leu 165(A)
Val 184(A)
Laq 401(A)Lys 133(A)
HOH 1092(A)
MG 1(B)
Asn 121(A)
Ser 182(A)
HOH 663(A)
Val 180(A)
Gly 75(A)
HOH 601(A)
HOH 751(A)
HOH 777(A)
HOH 1036(A)
Phe 78(A)
Arg 181(A)
Asn 83(A)
Thr 151(A)
Thr 178(A)
Ala 76(A)
4
2.50HOH 935(A)
FIGURE S2. Schematic diagram showing interactions between lipoyl-AMP and LplA. Lipoyl-AMP and LplA residues interacting with lipoyl-AMP are shown in a flattened form. Lipoyl-AMP atoms with short red lines represent hydrophobic interactions pointing toward the LplA residues also outlined with red lines. Green dashed lines show potential hydrogen bonds between atoms with distances in Å.
SNVPAEL 7ALRMWASSTANALKLSSSSRLHLSPTFSISRCFSNVLDGL 40
KYSKEHEWLRKEADGTYTVGITEHAQELLGDMVFVDLPEV 47KYAPSHEWVKHEGS-VATIGITDHAQDHLGEVVFVELPEP 80
GATVSAGDDCAVAESVKAASDIYAPVSGEIVAVNDALSDS 87GVSVTKGKGFGAVESVKATSDVNSPISGEVIEVNTGLTGK 120
PELVNSEPYAGGWIFKIKASDESELESLLDATAYEALLED 127 PGLINSSPYEDGWMIKIKPTSPDELESLLGAKEYTKFCEE 160
E 128 EDAAH 165
β1
β9
β8β7β6β5
β4β3β2
α5α4α3
α2
α1
Ec apoHPea H
Ec apoHPea H
Ec apoHPea H
Ec apoHPea H
Ec apoHPea H
Supplemental Figure S3
A
5
FIGURE S3. Structure of E. coli apoH-protein. A, amino acid sequence alignment of E. coli apoH-protein (Ec apoH) with pea H-protein (pea H). Residues in red are identical in two proteins. Orange rectangles and blue arrows represent α-helices and β-strands, respectively. Red arrowhead shows the lysine residue which accepts lipoic acid. B, apoH-protein of molB (orange), molD (cyan), and in its free form (gray) are superimposed and shown in stereo form. Lys64 is shown as a stick model. Secondary structural elements and N- and C-termini are labeled.
CC
N α1
β8
β7
β6
β5β4
β3
β2
β1
α5
α4α3
α2
N α1
β8
β7
β6
β5β4
β3
β2
β1
α5
α4α3
α2
K64K64
β9 β9
B
Supplementa1 Figure S4
A
B
FIGURE S4. Structure of LplA-octyl-AMP-apoH-protein complex. A, stereo view of the ternary complex (molA-molB). LplA is colored in cyan, and apoH-protein is in purple. Octyl-AMP is in orange (bond) and atom-type colors. Secondary structural elements of apoH-protein and N- and C-termini are labeled. B, schematic diagram showing interactions between LplA and octyl-AMP (molA). Potential hydrogen bonds and hydrophobic interactions are shown as in Fig. S2.
3.33
2.80
2.72
2.97
3.14
2.94
2.87
2.91
C1 O3P
C8
C7
C6
C5 C4
C3 C2
P
O2P
O1P O5*
C5*
C4*
O4*
C3*
C1*
O3*
C2* O2*
N9 C8
C4 N7
C5
C6
N3
C2
N1 N6
N
CA
CB
C
CG
CD
CE
NZ
O
N
CA
CB C
OG1
CG2
O
N
CA CB
C CG
CD1
CD2
CE1 CZ
CE2
O
N
CA
CB
C
CG
OD1
ND2
O
N
CA
CB
C
CG1
CG2
O
N
CA
CB C
OG O
N
CA
C
O
Val 77(A)
Trp 37(A)
His 149(A)
Arg 70(A)
His 79(A)
Ser 135(A)
Gly 136(A)
Leu 153(A)
Leu 165(A)
Val 184(A)
Oct 401(A)
Amp 402(A)
Lys 133(A)
Thr 151(A)
Phe 78(A)
Asn 83(A)
Val 180(A)
Ser 182(A)
Gly 75(A)
6
LplA
N
C
N
C N
C
N
C
apoH-proteinapoH-protein
LplA
β7 β7
β8
β7
α4
α5 α5
β4α2α2
β4
β7
β8α1
α3α3
α1
β8β5 β5
β3β3
β1β2β2
β9
β8
β9
β1
β6β6
α4
Supplemental Figure S5
α1
β1
α11
α10
α9
α8
α7
α6
α5
α4
α3
α2
β13
β12
β11
β10
β9
β8
β7
β6
β5β4
β3
β2
N
C
K168
K187α1
β1
α11
α10
α9
α8
α7
α6
α5
α4
α3
α2
β13
β12
β11
β10
β9
β8
β7
β6
β5β4
β3
β2
N
C
K168
K187
7
FIGURE S5. Structure of bovine lipoyltransferase in unliganded form. The structure of bovine lipoyltransferase in its unliganded form (green) is superimposed onto that in complex with lipoyl-AMP (gray, PDB ID: 2E5A) with the root mean square deviation of 0.93 Å (for 267 Cα atoms of 311). Lipoyl-AMP in the complex is in gray (bond) and atom-type colors. The loop in the complex form (residues 169−186), which is disordered in the unliganded form, is in magenta. N- and C-termini, positions of K168 and K187, and secondary structural elements are labeled.
Supplemental Figure S6
FIGURE S6. HPCL analysis of lipoyl-AMP produced by lipoate-adenylation reaction. A, standard lipoyl-AMP (3.99 nmol). B, C, D, E, F, and G, reaction products by wild-type LplA, K133A, N121A, D122A, S72A, and H149A mutant-LplA were resolved on a C18 column, respectively. Experiments were carried out two or three times, and representative data are shown. Line, absorbance at 258 nm; dashed line, concentration of acetonitrile. Results were summarized in Table 2.
Abs
orba
nce
at 2
58 n
m
Ace
toni
trile
(%
)
1.000
40
80
Lipoyl-AMP
1.000
1.000
0 15 30 45Retention time (min)
A: STD
0
0
0
0
1.000
0
8
1.000
0
G: H149A
F: S72A
E: D122A
1.000 D: N121A
C: K133A
1.000LplA
0
B: Wild-type